ArticleTrials2023

Rivaroxaban in patients with abdominal aortic aneurysm and high-sensitivity C-reactive protein elevation (BANBOO): study protocol for a randomized, controlled trial.

Jingyuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.